WebApr 10, 2024 · Contact: Cytokinetics Diane Weiser Senior Vice President, Corporate Communications, Investor Relations (415) 290-7757. Tags CYTK ... WebJan 7, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors. Our Vision. ... Email Alerts . Cytokinetics’ unparalleled expertise has kept it at the forefront of drug discovery and development for diseases impacting muscle performance.
Karen Thomsen - Director, Ph.. - Cytokinetics *Verified* ZoomInfo
WebApr 10, 2024 · SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated ( Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to participate in a fireside chat at the 22 nd Annual Needham Virtual Healthcare Conference on Monday, April 17, 2024 at 10:00 AM Eastern … WebAddress: 350 Oyster Point Blvd South San Francisco, CA, 94080-1912 United States See other locations Phone: ? Website: www.cytokinetics.com Employees (this site): ? Modelled Employees (all sites): ? Actual Revenue: $94.59 million Actual Sales Growth: 26.15% Assets: $841 Fiscal Year End: DEC Year Started: ? Incorporated: ? csr crs
Cytokinetics, Incorporated Company Profile - Dun
WebThe most common Cytokinetics email format is [first_initial] [last] (ex. [email protected]), which is being used by 100.0% of Cytokinetics work email addresses. Other common Cytokinetics email patterns are [first] (ex. [email protected]) and [last] (ex. [email protected]). In all, Cytokinetics uses 4 … WebAt Cytokinetics, our values and commitment to corporate social responsibility encourage giving to organizations that are aligned with our therapeutic areas of interest. We provide grants and charitable support to a diverse group of organizations that we believe make a … WebCytokinetics: Contact Details and Business Profile Company Information Email Format Management Cytokinetics Information Cytokinetics is a different kind of company. It is increasingly unusual that an emerging growth biotechnology company would be dedicated to the discovery, development and commercialization of therapeutics. eangus financial assistance